Complejo Hospitalario de Navarra

Pamplona/ Navarra 31008

0 studies enrolling now · 2 studies all time

What they study most

Antimetabolites, Antineoplastic, Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, Endocrine System Diseases, Gemcitabine, Multiple Sclerosis, Neoplasms, Neoplasms by Site, Pancreatic Diseases, Pancreatic Neoplasms

Studies at this site

• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed